Cargando…

Editorial: Novel Platform for Antigen Delivery to Dendritic Cells for Immunotherapy

Detalles Bibliográficos
Autores principales:	Plantinga, Maud, Affandi, Alsya J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197410/ https://www.ncbi.nlm.nih.gov/pubmed/35711423 http://dx.doi.org/10.3389/fimmu.2022.915604

Ejemplares similares

CD169(+) Macrophages Capture and Dendritic Cells Instruct: The Interplay of the Gatekeeper and the General of the Immune System
por: Grabowska, Joanna, et al.
Publicado: (2018)

Delivery of antigen to porcine dendritic cells by fusing antigen with porcine dendritic cells targeting peptide
por: Xia, Tian, et al.
Publicado: (2022)

Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
por: Dolcetti, Riccardo, et al.
Publicado: (2020)

Dendritic Cell Therapy in an Allogeneic-Hematopoietic Cell Transplantation Setting: An Effective Strategy toward Better Disease Control?
por: Plantinga, Maud, et al.
Publicado: (2014)

Expression of XCR1 Characterizes the Batf3-Dependent Lineage of Dendritic Cells Capable of Antigen Cross-Presentation
por: Bachem, Annabell, et al.
Publicado: (2012)

Incorporation of Toll-Like Receptor Ligands and Inflammasome Stimuli in GM3 Liposomes to Induce Dendritic Cell Maturation and T Cell Responses
por: Nijen Twilhaar, Maarten K., et al.
Publicado: (2022)

Dendritic Cells and Their Role in Immunotherapy
por: Gardner, Alycia, et al.
Publicado: (2020)

Current State of Dendritic Cell-Based Immunotherapy: Opportunities for in vitro Antigen Loading of Different DC Subsets?
por: Huber, Anne, et al.
Publicado: (2018)

Dendritic Cell-Based Immunotherapy for Myeloid Leukemias
por: Schürch, Christian M., et al.
Publicado: (2013)

Regulatory Dendritic Cells for Immunotherapy in Immunologic Diseases
por: Gordon, John R., et al.
Publicado: (2014)

Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy
por: Peng, Xin, et al.
Publicado: (2021)

Dendritic Cell-Based Immunotherapy in Lung Cancer
por: Stevens, Dieter, et al.
Publicado: (2021)

Editorial: Immune Responses to Persistent or Recurrent Antigens: Implications for Immunological Memory and Immunotherapy
por: Caserta, Stefano, et al.
Publicado: (2021)

Editorial: Targeted Antigen Delivery: Bridging Innate and Adaptive Immunity
por: Manoury, Bénédicte, et al.
Publicado: (2019)

Editorial: NKT Cells in Cancer Immunotherapy
por: Webb, Tonya J., et al.
Publicado: (2020)

Targeted Delivery of Toxoplasma gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency against Toxoplasmosis
por: Lakhrif, Zineb, et al.
Publicado: (2018)

Dendritic cells enhance the antigen sensitivity of T cells
por: Garbi, Natalio, et al.
Publicado: (2012)

Conventional dendritic cells type 1 are strongly enriched, quiescent and relatively tolerogenic in local inflammatory arthritis
por: Boltjes, Arjan, et al.
Publicado: (2023)

Editorial: Novel biomarkers for predicting response to cancer immunotherapy
por: Huangfu, Shuchen, et al.
Publicado: (2023)

Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation
por: Zhuang, Quan, et al.
Publicado: (2020)

Upconversion nanoparticle platform for efficient dendritic cell antigen delivery and simultaneous tracking
por: Yu, Zhenfeng, et al.
Publicado: (2022)

Editorial: Dendritic Cell and Macrophage Nomenclature and Classification
por: Ginhoux, Florent, et al.
Publicado: (2016)

Editorial: Involvement of dendritic cells in gastrointestinal cancer
por: Ni, Ling, et al.
Publicado: (2023)

Self-Antigen Presentation by Dendritic Cells in Autoimmunity
por: Hopp, Ann-Katrin, et al.
Publicado: (2014)

Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy
por: van Gulijk, Mandy, et al.
Publicado: (2018)

Delivery of Antigen to CD8(+) Dendritic Cells by Fusing Antigen With Formyl Peptide Receptor-Like 1 Inhibitor Protein Induces Antitumor Immunity
por: Chiang, Chen-Yi, et al.
Publicado: (2019)

Clinical Grade Production of Wilms’ Tumor-1 Loaded Cord Blood-Derived Dendritic Cells to Prevent Relapse in Pediatric AML After Cord Blood Transplantation
por: Plantinga, Maud, et al.
Publicado: (2020)

Editorial: Combinational immunotherapy of cancer: novel targets, mechanisms, and strategies
por: Nan, Yanyang, et al.
Publicado: (2023)

Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma
por: Hargadon, Kristian M.
Publicado: (2017)

Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma
por: Gardam, Bryan, et al.
Publicado: (2023)

Editorial: Harnessing the Participation of Dendritic Cells in Immunity and Tolerance
por: Boscardin, Silvia Beatriz, et al.
Publicado: (2020)

Editorial: NK Cell-Based Cancer Immunotherapy
por: Borrego, Francisco, et al.
Publicado: (2016)

Erratum: Editorial: NKT Cells in Cancer Immunotherapy
Publicado: (2020)

Editorial: CD4(+) T Cells in Cancer Immunotherapies
por: González-Navajas, José M., et al.
Publicado: (2021)

Editorial: NK cells in viral immunology and immunotherapy
por: Mulik, Sachin, et al.
Publicado: (2023)

Editorial: Novel Immunotherapies Against Envenomings by Snakes and Other Venomous Animals
por: Laustsen, Andreas Hougaard, et al.
Publicado: (2020)

Editorial: Immunotherapy in Multiple Myeloma
por: Giuliani, Nicola, et al.
Publicado: (2019)

Advances in Human Dendritic Cell-Based Immunotherapy Against Gastrointestinal Cancer
por: Ni, Ling
Publicado: (2022)

Immunosuppression Reversal Nanovaccines Substituting Dendritic Cells for Personalized Cancer Immunotherapy
por: Chen, Hu, et al.
Publicado: (2022)

Dendritic Cells in Cancer Immunotherapy Clinical Trials: Are We Making Progress?
por: Butterfield, Lisa H.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sghrup4sg5p50mem7cb6bag6en